Structural contributions to the intracellular targeting strategies of antimicrobial peptides

Biochimica et Biophysica Acta - Biomembranes

Volumn 1798, Issue 10, 2010, Pages 1934-1943

  Lan, Yun ^a   Ye, Yan ^a   Kozlowska, Justyna ^a   Lam, Jenny K W ^a   Drake, Alex F ^a   Mason, A James ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Buforin II; CD spectroscopy; DNA binding; Magainin 2; Peptide antibiotics; Pleurocidin

Indexed keywords

BUFORIN 2; BUFORIN 2 AMIDE; DOUBLE STRANDED DNA; MAGAININ 2; MAGAININ 2 AMIDE; PLEUROCIDIN; POLYPEPTIDE ANTIBIOTIC AGENT; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; AMIDE; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; BACTERIAL DNA; BUFORIN II; FISH PROTEIN; MAGAININ DERIVATIVE; PEPTIDE; PROTEIN; PROTEIN BINDING;

ALPHA HELIX; AMIDATION; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL MEMBRANE; BINDING AFFINITY; CIRCULAR DICHROISM; CONTROLLED STUDY; DNA SEQUENCE; DRUG DNA BINDING; ESCHERICHIA COLI; FLUORESCENCE SPECTROSCOPY; GRAM NEGATIVE BACTERIUM; MEMBRANE DAMAGE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN STRUCTURE; PROTEIN TARGETING; PROTEIN TRANSPORT; AMINO ACID SEQUENCE; ANIMAL; BACTERIA; BINDING COMPETITION; CHEMISTRY; DRUG EFFECTS; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MOLECULAR GENETICS; PROTEIN SECONDARY STRUCTURE; SPECTROFLUOROMETRY;

AMIDES; AMINO ACID SEQUENCE; ANIMALS; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIA; BINDING, COMPETITIVE; CIRCULAR DICHROISM; DNA, BACTERIAL; ESCHERICHIA COLI; FISH PROTEINS; MAGAININS; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; PROTEINS; SPECTROMETRY, FLUORESCENCE;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; NEGIBACTERIA;

EID: 77955655670     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2010.07.003     Document Type: Article

References (44)

1. Hancock R.E.W., Sahl H.-G. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 2006, 24:1551-1557.
2. Reddy K.V.R., Yedery R.D., Aranha C. Antimicrobial peptides: premises and promises. Int. J. Antimicrob. Agents 2004, 24:536-547.
3. Marr A.K., Gooderham W.J., Hancock R.E.W. Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr. Opin. Pharmacol. 2006, 6:468-472.
4. Gordon Y.J., Romanowski E.G., McDermott A.M. A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs. Curr. Eye Res. 2005, 30:505-515.
5. Brogden K.A. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?. Nat. Rev. Microbiol. 2005, 3:238-250.
6. Hale J.D.F., Hancock R.E.W. Alternative mechanisms of action of cationic antimicrobial peptides on bacteria. Expert Rev. Anti Infect. Ther. 2007, 5:951-959.
7. Park C.B., Kim H.S., Kim S.C. Mechanism of action of the antimicrobial peptide buforin II: Buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem. Biophys. Res. Commun. 1998, 244:253-257.
8. Cirioni O., et al. Therapeutic efficacy of buforin II and rifampin in a rat model of Acinetobacter baumanii sepsis. Crit. Care Med. 2009, 37:1403-1407.
9. Uyterhoeven E.T., Butler C.H., Ko D., Elmore D.E. Investigating the nucleic acid interactions and antimicrobial mechanism of buforin II. FEBS Lett. 2008, 582:1715-1718.
10. Sreerama N., Woody R.W. Estimation of protein secondary structure from CD spectra: comparison of CONTIN, SELCON and CDSSTR methods with an expanded reference set. Anal. Biochem. 2000, 287:252-260.
11. Wiegand I., Hilpert K., Hancock R.E.W. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat. Protoc. 2008, 3:163-175.
12. Bechinger B., Zasloff M., Opella S.J. Structure and interactions of magainin antibiotic peptides in lipid bilayers: a solid-state nuclear magnetic resonance investigation. Biophys. J. 1992, 62:12-14.
13. Bechinger B., Zasloff M., Opella S.J. Structure and orientation of the antibiotic peptide magainin in membranes by solid-state nuclear magnetic resonance spectroscopy. Protein Sci. 1993, 2:2077-2084.
14. Bechinger B., Ruysschaert J.M., Goormaghtigh E. Membrane helix orientation from linear dichroism of infrared attenuated total reflection spectra. Biophys. J. 1999, 76:552-563.
15. Matsuzaki K., Murase O., Tokuda H., Funakoshi S., Fujii N., Miyajima K. Orientational and aggregational states of magainin 2 in phospholipid bilayers. Biochemistry 1994, 33:3342-3349.
16. Ludtke S.J., He K., Wu Y., Huang H.W. Cooperative membrane insertion of magainin correlated with its cytolytic activity. Biochim. Biophys. Acta 1994, 1190:181-184.
17. Yi G.-S., Park C.B., Kim S.C., Cheong C. Solution structure of an antimicrobial peptide buforin II. FEBS Lett. 1996, 398:87-90.
18. Boger D.L., Tse W.C. Thiazole Orange as the fluorescent intercalator in a high resolution FID assay for determining DNA binding affinity and sequence selectivity of small molecules. Bioorg. Med. Chem. 2001, 9:2511-2518.
19. Woody R.W. Circular dichroism spectrum of peptides in poly(pro)II conformation. J. Am. Chem. Soc. 2009, 131:8234-8245.
20. Durfee T., et al. The complete genome sequence of Escherichia coli DH10B: insights into the biology of a laboratory workhorse. J. Bacteriol. 2008, 190:2597-2606.
21. Park C.B., Kim M.S., Kim S.C. A novel antimicrobial peptide from Bufo bufo gargarizans. Biochem. Biophys. Res. Commun. 1996, 218:408-413.
22. Kobayashi S., Chikushi A., Tougu S., Imura Y., Nishida M., Yano Y., Matsuzaki K. Membrane translocation mechanism of the antimicrobial peptide buforin 2. Biochemistry 2004, 43:15610-15616.
23. Rathinakumar R., Walkenhorst W.F., Wimley W.C. Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: the importance of interfacial activity. J. Am. Chem. Soc. 2009, 131:7609-7617.
24. Epand R.M., Rotem S., Mor A., Berno B., Epand R.F. Bacterial membranes as predictors of antimicrobial potency. J. Am. Chem. Soc. 2008, 130:14346-14352.
25. Gregory S.M., Pokorny A., Almeida P.F.F. Magainin 2 revisited: a test of the Quantitative Model for the all-or-none permeabilization of phospholipid vesicles. Biophys. J. 2009, 96:116-131.
26. Almeida P.F.F., Pokorny A. Mechanisms of antimicrobial, cytolytic, and cell-penetrating peptides: from kinetics to thermodynamics. Biochemistry 2009, 48:8083-8093.
27. Gottler L.M., Ramamoorthy A. Structure, membrane orientation, mechanism, and function of pexiganan-a highly potent antimicrobial peptide designed from magainin. Biochim. Biophys. Acta 2009, 1788:1680-1686.
28. Ludtke S.J., He K., Heller W.T., Harroun T.A., Yang L., Huang H.W. Membrane pores induced by magainin. Biochemistry 1996, 35:13723-13728.
29. Huang H.W. Molecular mechanism of antimicrobial peptides: the origin of cooperativity. Biochim. Biophys. Acta 2006, 1758:1292-1302.
30. Leontiadou H., Mark A.E., Marrink S.J. Antimicrobial peptides in action. J. Am. Chem. Soc. 2006, 128:12156-12161.
31. Mason A.J., Chotimah I.N.H., Bertani P., Bechinger B. A spectroscopic study of the membrane interaction of the antimicrobial peptide Pleurocidin. Mol. Membr. Biol. 2006, 23:185-194.
32. Saint N., Cadiou H., Bessin Y., Molle G. Antibacterial peptide pleurocidin forms ion channels in planar lipid bilayers. Biochim. Biophys. Acta 2002, 1564:359-364.
33. Mason A.J., et al. Structural determinants of antimicrobial and antiplasmodial activity and selectivity in histidine-rich amphipathic cationic peptides. J. Biol. Chem. 2009, 284:119-133.
34. Cho J.H., Sung B.H., Kim S.C. Buforins: histone H2A-derived antimicrobial peptides from toad stomach. Biochim. Biophys. Acta 2009, 1788:1564-1569.
35. Kobayashi S., Takeshima K., Park C.B., Kim S.C., Matsuzaki K. Interactions of the novel antimicrobial peptide Buforin 2 with lipid bilayers: proline as a translocation promoting factor. Biochemistry 2000, 39(2000):8648-8654.
36. Park C.B., Yi K.-S., Matsuzaki K., Kim M.S., Kim S.C. Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell penetrating ability of buforin II. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:8245-8250.
37. Fleming E., Maharaj N.P., Chen J.L., Nelson R.B., Elmore D.E. Effect of lipid composition on buforin II structure and membrane entry. Proteins 2008, 73:480-491.
38. Mason A.J., Marquette A., Bechinger B. Zwitterionic phospholipids and sterols modulate antimicrobial peptide-induced membrane destabilization. Biophys. J. 2007, 93:4289-4299.
39. 2H-NMR studies of phospholipids differing in headgroup structure and chain length. Eur. Biophys. J. 1994, 23:323-335.
40. Pan Y.-L., Cheng J.T.-J., Hale J., Pan J., Hancock R.E.W., Straus S.K. Characterization of the structure and membrane interaction of the antimicrobial peptides Aurein 2.2 and 2.3 from Australian southern bell frogs. Biophys. J. 2007, 92:2854-2864.
41. Tinoco I., Bustamente C., Maestre M.F. The optical activity of nucleic acids and their aggregates. Annu. Rev. Biophys. Bioeng. 1980, 9:107-141.
42. Phillips C.L., Mickols W.E., Maestre M.F., Tinoco I. Circular differential scattering and circular differential absorption of DNA-protein condensates and of dyes bound to DNA-protein condensates. Biochemistry 1986, 25:7803-7811.
43. Patrzykat A., Friedrich C.L., Zhang L., Mendoza V., Hancock R.E.W. Sublethal concentrations of Pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli. Antimicrob. Agents Chemother. 2002, 46:605-614.
44. Eisenberg D., Weiss R.M., Terwilliger C.T., Wilcox W. Hydrophobic moments and protein structure. Faraday Symp. Chem. Soc. 1982, 17:109-120.